Dr. Steven G. Dunder, MD

Dr. Dunder practices at Cancer Partners of Nebraska in Lincoln, Nebraska.

Dr. Dunder's NPI, 1346264546, was assigned on July 27, 2006. Dr. Dunder graduated from UNMC in 1999. Dr. Dunder holds Nebraska license 25453.

Dr. Dunder's primary practice is Cancer Partners of Nebraska, at 201 S 68th Street Pl, Lincoln, NE 68510 in Lancaster County. The practice phone is (402) 420-7000.

Dr. Dunder's primary practice is Cancer Partners of Nebraska in Lincoln, Nebraska. Dr. Dunder is also affiliated with Bryan Medical Center. The medical group on file is Cancer Partners of Nebraska. Dmand AI also links Dr. Dunder to 4 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunder practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dunder's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dunder is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Dunder's licenses on file in 4 states: Nebraska, North Carolina, South Carolina and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Dunder treats.

CMS data shows 106,060 Medicare services from Dr. Dunder across 78 procedure codes in 2024, for 967 Medicare patients. Medicare paid $1,629,692 for them.

CMS counts 967 Medicare patients who saw Dr. Dunder in 2024. The largest group is 65 to 74, with 463 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dunder's median patient age at 69, with 62% women.

In 2024, Dr. Dunder wrote 1,154 Medicare Part D claims for 198 patients. 75% of them were for generic drugs. CMS names the drug for 988 of them, across 22 drugs with 11 or more claims each, at $2,453,237 in total drug cost. In 2023, CMS named 854 claims across 20 drugs.

Dr. Dunder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Dunder, published from 2007 to 2019. Dr. Dunder's most frequent co-authors are Uzair Bashir Chaudhary, MD, Mehmet Sitki Copur, MD and Jhanelle E. Gray, MD.

Dmand AI links Dr. Dunder to 1 clinical trial. Conditions studied include Multiple Endocrine Neoplasia Type 1 and Multiple Endocrine Neoplasia.

CMS Open Payments shows 1,157 general payments to Dr. Dunder from 91 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Innovative Blood Resources paid the most, $5,833.

Dmand AI lists 1 award for Dr. Dunder, most recently CMS Stage 1 2012 in 2012.

Dr. Dunder graduated from UNMC in 1999. Dr. Dunder is a member of ASCO.

Dr. Dunder is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.